ZBH zimmerbiomet.com: Book Valuation of Business

Public company logo of Zimmer (ZBH)

The market valuation dynamics for Zimmer Biomet Holdings (ZBH), which reached 12.63, are based on its ownership of a global network of sterile plants that guarantee an uninterrupted supply to medical centers. To mitigate dependence on a single segment, the company is implementing digital IT solutions and software for patient monitoring. Business revenues are generated through the sale of robotic systems and joint prosthetics.

ZBH - Zimmer Biomet Holdings Book Capitalization over the range 07/04/2022 - 10/30/2026
Manufactured product of zimmerbiomet.com

To minimize fundamental analysis risks, tracking asset values in real time is critically important. Stable plant utilization at Zimmer Biomet Holdings (ZBH) and equipment modernization confirm the high material resilience of the business. The current value of 12.63 is calculated as the issuer's daily net asset value. The trend of the company's net balance sheet assets on this chart eliminates distortions from infrequent quarterly reporting. The linear trend here indicates conservative yet reliable capital management.

Competitor analysis

Accounting Value of Company BSX (Boston Scientific Corporation Inc.)|Edwards Lifesciences (EW) - Company Book Value|RMD - Book Valuation of Business|Company Book Value Insulet|The Cooper Companies, Inc. - Net Asset Value|Book Capitalization ALGN|GMED - Total Stockholders' Equity|Book Capitalization TMDX (TransMedics Corp)|ATEC - Company Net Assets|Artivion - Book Capitalization|Book Valuation of Business Enovis Corp ENOV|IART: Book Capitalization|Establishment Labs Inc (ESTA) - Book Capitalization|Company Book Value Beta Bionics Inc|Company Book Value IRMD|Book Capitalization EMBC|Book Valuation of Business Tandem Diabetes Care Inc|Axogen Corp - Company Net Assets|SIBN (SI-BONE Medical) - Net Asset Value|Orthofix Medical Inc. - Book Capitalization|Total Stockholders' Equity bioventus.com|KIDS: Book Capitalization|Accounting Capitalization TMCI|Company Net Assets SRTA|CARL: Accounting Value of Company|Company Book Value RxSight, Inc. (RXST)|Company Net Assets clearpointneuro.com CLPT|Book Capitalization STXS (Stereotaxis)|Neuronetics Inc. (STIM) - Total Stockholders' Equity|Sight Sciences, Inc - Book Capitalization|OBIO (Orchestra BioMed Inc.) - Accounting Capitalization|ANIK: Book Capitalization|NSPR - Book Valuation of Business|ZJYL (Jin Medical International Ltd.) - Book Capitalization|Company Net Assets Vivani (VANI)|Book Capitalization XTNT|Book Capitalization NeuroOne Medical Technologies Corp. (NMTC)|Company Book Value Modular Medical, Inc. MODD|myomo.com - Company Book Value|COCH: Company Net Assets|Accounting Value of Company VVOS (Vivos Therapeutics Inc.)|NVNO: Book Capitalization|Total Stockholders' Equity Sintx Technologies, Inc. (SINT)|Company Book Value Tenon Medical, Inc.|LFWD - Book Value of Business|Company Net Assets AMIX (Autonomix Medical, Inc.)|Book Capitalization INVO Bioscience (IVF)|Book Capitalization BBLG (Bone Biologics Corporation)|Book Valuation of Business Axonics, Inc (AXNX)|BIOL - Company Book Value|Net Asset Value DYNT|paragon28.com (FNA) - Company Book Value|Company Net Assets INVO Bioscience